Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA mutation carriers' perception about benefits and risks associated with combined hormonal contraceptives use.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception - 1 Dec 2022

Grandi Giovanni, Monari Francesca, Boggio Sola Valentina, Cortesi Laura, Toss Angela, Del Savio Maria Chiara, Melotti Chiara, Centurioni Maria Grazia, Gustavino Claudio, Varesco Liliana, Facchinetti Fabio, Barra Fabio

Abstract excerpt

OBJECTIVE: To evaluate the actual perceptions about combined hormonal contraceptives (CHCs) use in BRCA mutation carriers in comparison to women from the general population. METHODS: This was a cross-sectional, observational study involving two Italian referral centres for hereditary cancers. An identical questionnaire investigating how CHC use could affect the risk of developing some types of cancer, specific...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross-Sectional Studies
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Health Knowledge, Attitudes, Practice

Share to Heterozygote

Share to Mutation

Share to Perception

Share to Risk Assessment

Source

Identifiers

PMID: 35946412
DOI: 10.1080/13625187.2022.2107199

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA mutation carriers' perception about benefits and risks associated with combined hormonal contraceptives use.PMID 35946412Read ↗

BRCA mutation carriers' perceptions on postmenopausal hormone therapy: An Italian study.Semantic proximity Read ↗

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.Semantic proximity Read ↗

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.Semantic proximity Read ↗

Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.Semantic proximity Read ↗

Oral contraceptive use and BRCA penetrance: a case-only study.Semantic proximity Read ↗

Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.Semantic proximity Read ↗

Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.Semantic proximity Read ↗

Use of exogenous hormones in those at increased risk for breast cancer: contraceptive and menopausal hormones in gene carriers and other high-risk patients.Semantic proximity Read ↗

Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.Semantic proximity Read ↗

Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.Semantic proximity Read ↗

Factors Impacting on Decision-Making towards Prophylactic Surgeries in BRCA Mutation Carriers and Women with Familial PredispositionSemantic proximity Read ↗

Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.